title: The effect of morphine and naloxone administration on maternal oxytocin concentration in late pregnancy.
abstract: OBJECTIVE
  Modification of the inhibitory control of oxytocin secretion by endogenous opiates in late pregnancy may be one of the factors involved in the onset of labour. The interrelationships between exogenously administered opioids and oxytocin may demonstrate activity of this control mechanism. This study was undertaken to investigate the effect of an opiate and an opiate antagonist on maternal oxytocin levels in late pregnancy.
  
  
  METHODS
  Patients were randomized to receive either morphine (5 mg), naloxone (2.4 mg) or sterile water (1 ml) intravenously.
  
  
  METHODS
  Thirty women with singleton pregnancies greater than 36 weeks gestation who were not in labour were studied.
  
  
  METHODS
  Blood for peripheral oxytocin levels was sampled every 2.5 minutes for 15 minutes before and 15 minutes after administration of the assigned substance. Oxytoxin was measured by radioimmunoassay. Peripheral beta-endorphin levels were measured at the beginning and end of the study.
  
  
  RESULTS
  There was no significant change in the maternal oxytocin concentration after administration of either morphine, naloxone or sterile water compared to pretreatment levels. beta-Endorphin levels did not change significantly, either from the beginning to the end of the study, or between groups.
  
  
  CONCLUSIONS
  In late pregnancy exogenous opiates and opiate antagonists have no effect on maternal peripheral oxytocin levels.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Cape Town, Medical School, Observatory, South Africa.
authors.forename: S W
authors.initials: SW
authors.lastname: Lindow
authors.forename: Z M
authors.initials: ZM
authors.lastname: van der Spuy
authors.forename: M S
authors.initials: MS
authors.lastname: Hendricks
authors.forename: F A
authors.initials: FA
authors.lastname: Nugent
authors.forename: T T
authors.initials: TT
authors.lastname: Dunne
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology*; D010121:Oxytocin / Q000097:blood*; D011247:Pregnancy / Q000097:blood*; D011263:Pregnancy Trimester, Third; D011863:Radioimmunoassay; D001615:beta-Endorphin / Q000097:blood
chemical_list: D009270:Naloxone; D010121:Oxytocin; D001615:beta-Endorphin; D009020:Morphine